fbpx

Vision for Life Announces Financial Support to Help Primary Vision Care Providers During COVID-19

Essilor’s social impact fund, Vision for Life™, announced a €300,000 financial support scheme to help over 1,800 vulnerable primary vision care providers, whose livelihoods are at risk due to the ongoing COVID-19 pandemic.

These primary vision care providers are based in five countries – India, Bangladesh, Indonesia, Cambodia and Kenya – and will each receive a cash assistance sum, equivalent to one month’s income.

These primary vision care providers are mainly micro-entrepreneurs trained under Essilor’s Eye Mitra (friend of the eyes in Hindi) program, first launched in India in 2013 and subsequently expanded and adapted to different countries around the world. Today there are over 16,000 primary vision care providers globally, providing sustainable access to vision care for over 320 million people.

The pandemic has seen many countries impose stringent lockdown measures to contain the spread of the virus, impacting a lot of businesses, including the network of primary vision care providers. They have been forced to close or operate under restricted conditions. Even as countries emerge from lockdowns, business has not returned to normal for these vision care providers. A recent survey conducted by Essilor found that a number of them do not have enough savings to sustain prolonged business closures and are the only source of income for their families.

The cash assistance sum is equivalent to one month’s income for each primary vision care provider and will be disbursed to each primary vision care provider with the help of local NGO partners. Essilor has earlier issued personal protective equipment, safety tips as well as advisories on the safe handling and usage of eyeglasses to stem the spread of COVID-19 to its entire network of primary vision care providers. It is also providing online training, enabling them to upskill during this period. In addition, the Essilor teams are investigating relevant support schemes and assistance programs within each country and helping the vision care providers apply for them.

Click HERE for the full press release.

Featured Posts

Optik VOILA January-February 2026 Lanctôt JOS980006_40-petrol-dark-gun

JOS: Titan Bold

JOS Titan Bold is a men’s frame crafted from pure titanium, featuring bevelled edges, masculine matte tones, and beta-titanium temples for durability, flexibility, and refined fit.

Learn More
EQ-based strategies for coping with depression

How to Cope with Depression: An EQ-Based Guide for Professionals

In today’s workplace, stress isn’t just common, it’s constant. Shifting expectations, increased workloads, ever-changing schedules, difficult colleagues, and the pressure to “perform with a smile” can stretch even the highest-achieving professionals thin.

Read more
ClearVision logo

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

ClearVision Optical recognizes Monica Van Duyne as the 2025 Fred Friedfeld Memorial Scholarship recipient, supporting optometry education.

Read more
Vision Expo new logo

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

Vision Expo returns to Orlando in March 2026 as a unified annual event, featuring accredited education, new product launches and a 40th anniversary celebration.

Read more
CRO logo image for Research Updates in Optik magazine

Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration

A 2025 review highlights evidence linking vitamins B6, B9 and B12 to reduced risk and slower progression of age-related macular degeneration, with AREDS3 set to explore added benefit.

Read more
Optik VOILA January-February 2026 Lanctôt JOS980006_40-petrol-dark-gun

JOS: Titan Bold

JOS Titan Bold is a men’s frame crafted from pure titanium, featuring bevelled edges, masculine matte tones, and beta-titanium temples for durability, flexibility, and refined fit.

Learn More
EQ-based strategies for coping with depression

How to Cope with Depression: An EQ-Based Guide for Professionals

In today’s workplace, stress isn’t just common, it’s constant. Shifting expectations, increased workloads, ever-changing schedules, difficult colleagues, and the pressure to “perform with a smile” can stretch even the highest-achieving professionals thin.

Read More
ClearVision logo

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

ClearVision Optical recognizes Monica Van Duyne as the 2025 Fred Friedfeld Memorial Scholarship recipient, supporting optometry education.

Read More
Vision Expo new logo

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

Vision Expo returns to Orlando in March 2026 as a unified annual event, featuring accredited education, new product launches and a 40th anniversary celebration.

Read More
CRO logo image for Research Updates in Optik magazine

Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration

A 2025 review highlights evidence linking vitamins B6, B9 and B12 to reduced risk and slower progression of age-related macular degeneration, with AREDS3 set to explore added benefit.

Read More
Optik VOILA January-February 2026 Lanctôt JOS980006_40-petrol-dark-gun

JOS: Titan Bold

JOS Titan Bold is a men’s frame crafted from pure titanium, featuring bevelled edges, masculine matte tones, and beta-titanium temples for durability, flexibility, and refined fit.

Learn More
EQ-based strategies for coping with depression

How to Cope with Depression: An EQ-Based Guide for Professionals

In today’s workplace, stress isn’t just common, it’s constant. Shifting expectations, increased workloads, ever-changing schedules, difficult colleagues, and the pressure to “perform with a smile” can stretch even the highest-achieving professionals thin.

Read more
ClearVision logo

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

ClearVision Optical recognizes Monica Van Duyne as the 2025 Fred Friedfeld Memorial Scholarship recipient, supporting optometry education.

Read more
Vision Expo new logo

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

Vision Expo returns to Orlando in March 2026 as a unified annual event, featuring accredited education, new product launches and a 40th anniversary celebration.

Read more
CRO logo image for Research Updates in Optik magazine

Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration

A 2025 review highlights evidence linking vitamins B6, B9 and B12 to reduced risk and slower progression of age-related macular degeneration, with AREDS3 set to explore added benefit.

Read more
Optik VOILA January-February 2026 Lanctôt JOS980006_40-petrol-dark-gun

JOS: Titan Bold

JOS Titan Bold is a men’s frame crafted from pure titanium, featuring bevelled edges, masculine matte tones, and beta-titanium temples for durability, flexibility, and refined fit.

Learn More
EQ-based strategies for coping with depression

How to Cope with Depression: An EQ-Based Guide for Professionals

In today’s workplace, stress isn’t just common, it’s constant. Shifting expectations, increased workloads, ever-changing schedules, difficult colleagues, and the pressure to “perform with a smile” can stretch even the highest-achieving professionals thin.

Read more
ClearVision logo

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

ClearVision Optical recognizes Monica Van Duyne as the 2025 Fred Friedfeld Memorial Scholarship recipient, supporting optometry education.

Read more
Vision Expo new logo

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

Vision Expo returns to Orlando in March 2026 as a unified annual event, featuring accredited education, new product launches and a 40th anniversary celebration.

Read more
CRO logo image for Research Updates in Optik magazine

Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration

A 2025 review highlights evidence linking vitamins B6, B9 and B12 to reduced risk and slower progression of age-related macular degeneration, with AREDS3 set to explore added benefit.

Read more